Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phasex is a specialized contract development and manufacturing organization (CDMO) and a pioneer in supercritical fluid (SCF) technology. Founded in 1981 and headquartered in North Andover, Massachusetts, the company utilizes supercritical carbon dioxide (scCO2) for the extraction, purification, and fractionation of complex materials. Phasex serves the biopharmaceutical, medical device, and natural products industries, providing critical services such as the purification of implantable medical polymers, the development of drug delivery nanoparticles, and the extraction of high-purity nutraceuticals. In November 2024, Phasex was acquired by Robertet, a global leader in natural raw materials, to expand its production capacity and expertise in the North American market. The company offers a full range of services from initial feasibility studies and R&D to large-scale commercial toll processing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phasex.